1.

Record Nr.

UNINA9910961837603321

Titolo

Scientific and policy considerations in developing smallpox vaccination options : a workshop summary / / Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies

Pubbl/distr/stampa

Washington, D.C., : National Academy Press, c2002

ISBN

0-309-16898-8

1-280-18311-X

9786610183111

0-309-56635-5

Edizione

[1st ed.]

Descrizione fisica

1 online resource (57 p.)

Disciplina

614.5

Soggetti

Smallpox - Vaccination

Smallpox vaccine

Biological warfare

Emergency medical services - United States

Medical policy - United States

Public health - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

This report summarizes the discussions of [a] meeting, held on June 15, 2002 in Washington, D.C.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""SCIENTIFIC AND POLICY CONSIDERATIONS IN DEVELOPING SMALLPOX VACCINATION OPTIONS""; ""Copyright""; ""INDEPENDENT REPORT REVIEWERS""; ""Contents""; ""INTRODUCTION""; ""OPENING REMARKS""; ""SCIENTIFIC BACKGROUND ON SMALLPOX AND SMALLPOX VACCINATION""; ""SMALLPOX DISEASE""; ""SMALLPOX CONTROL STRATEGIES AND VACCINE AVAILABILITY""; ""SMALLPOX VACCINATION: EFFICACY, AVAILABILITY, DURATION OF IMMUNITY, AND TIMING""; ""SMALLPOX VACCINATION SAFETY""; ""CDC-ACIP SMALLPOX VACCINATION POLICY REVIEW""; ""CDC�S DRAFT POLICY OPTIONS""; ""SUMMARY OF REGIONAL MEETINGS""

""THE MODELING BASIS FOR VACCINATION POLICY OPTIONS""""MODEL 1""; ""MODEL 2""; ""MODEL 3""; ""SOVIET OUTBREAK OF SMALLPOX""; ""LESSONS LEARNED FROM RAPID MOBILIZATION FOR ANTHRAX MASS



PROPHYLAXIS: IMPLICATIONS FOR SMALLPOX""; ""DISTRICT OF COLUMBIA""; ""ARLINGTON COUNTY, VIRGINIA""; ""MARYLAND""; ""EMERGENCY RESPONDERS""; ""EMERGENCY MEDICAL TECHNICIANS""; ""FIRE CHIEFS""; ""EMERGENCY SERVICES""; ""HEALTH CARE PROVIDERS""; ""NURSES""; ""EMERGENCY ROOM PHYSICIANS""; ""FAMILY PHYSICIANS""; ""PEDIATRICIANS""; ""HOSPITAL WORKERS""; ""HOSPITAL SYSTEMS""; ""SPECIAL POPULATIONS""

""ETHICAL, LEGAL, AND SOCIAL ISSUES""""ETHICAL CONSIDERATIONS""; ""INDEMNIFICATION FOR ADVERSE EVENTS""; ""COMMUNICATION""; ""RISK COMMUNICATION""; ""PUBLIC HEALTH RISKS AND BENEFITS""; ""PERSPECTIVE 1""; ""PERSPECTIVE 2""; ""PERSPECTIVE 3""; ""PERSPECTIVE 4""; ""PUBLIC COMMENTS AND DISCUSSION""; ""USE OF SCARCE PUBLIC HEALTH RESOURCES AND INSURING DUAL USE APPROACHES""; ""VACCINE DEVELOPMENT AND APPROVAL""; ""INTERNATIONAL CONSIDERATIONS""; ""UNCERTAINTIES""; ""COMMUNICATION AND EDUCATION""; ""EPILOGUE""

""DRAFT SUPPLEMENTAL RECOMMENDATIONS OF THE ACIP USE OF SMALLPOX (VACCINIA) VACCINE, JUNE 2002""""PRE-RELEASE VACCINATION OF THE GENERAL POPULATION""; ""PRE-RELEASE VACCINATION OF SELECTED GROUPS TO ENHANCE SMALLPOX RESPONSE READINESS""; ""Smallpox Response Teams""; ""Designated Smallpox Healthcare Personnel at Designated Hospitals""; ""Implementation of Recommendations""

Sommario/riassunto

At the World Health Assembly in May 1980, the World Health Organization declared the world free of smallpox. Smallpox vaccination of civilians is now indicated only for laboratory workers directly involved with smallpox or closely related orthopox viruses. However recent questions raised by the terrorist attacks in fall 2001 have renewed concerns about possible outbreaks of smallpox resulting from its use as a biological weapon. In June 2002, the Institute of Medicine convened a public conference to discuss the scientific, clinical, procedural, and administrative aspects of various immunization strategies. Scientific and Policy Considerations in Developing Smallpox Vaccination Options summarizes the presentations and discussions from this workshop.